| Company Name: |
TOKYO CHEMICAL INDUSTRY CO., LTD.
|
| Tel: |
03-36680489 |
| Email: |
Sales-JP@TCIchemicals.com |
| Products Intro: |
Product Name:4,4'''-Bis(2-butyloctyloxy)-p-quaterphenyl CAS:18434-08-7 Purity:95-98% Package:200 mg,1 g
|
| Company Name: |
TCI Europe
|
| Tel: |
320-37350700 |
| Email: |
sales@tcieurope.eu |
| Products Intro: |
Product Name:4,4'''-Bis(2-butyloctyloxy)-p-quaterphenyl CAS:18434-08-7 Purity:95-98% Package:200 mg,1 g
|
| Company Name: |
TCI AMERICA
|
| Tel: |
800-4238616 |
| Email: |
sales@tciamerica.com |
| Products Intro: |
Product Name:4,4'''-Bis(2-butyloctyloxy)-p-quaterphenyl CAS:18434-08-7 Purity:95-98% Package:200 mg,1 g
|
4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl manufacturers
|
| | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl Basic information |
| Product Name: | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl | | Synonyms: | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl;4,4''''''-(2-butyloctyloxy)-p-quaterphenyl;4,4'''-Bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterbenzene;4,4'''-Bis[(2-butyloctyl)oxy]-p-quaterphenyl;Ccris 4969;Einecs 242-310-0;1,1':4',1'':4'',1'''-Quaterphenyl, 4,4'''-bis[(2-butyloctyl)oxy]-;4,4'''-Bis(2-butyloctyloxy)-p-quaterphenyl | | CAS: | 18434-08-7 | | MF: | C48H66O2 | | MW: | 675.04 | | EINECS: | 242-310-0 | | Product Categories: | | | Mol File: | 18434-08-7.mol | ![4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl Structure](CAS/GIF/18434-08-7.gif) |
| | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl Chemical Properties |
| Melting point | 163°C(lit.) | | Boiling point | 763.3±55.0 °C(Predicted) | | density | 0.968±0.06 g/cm3(Predicted) | | form | powder to crystal | | color | White to Almost white |
| | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl Usage And Synthesis |
| Description | BiBuQ is a bioactive compound widely used in the discovery of anti-cancer drugs. It hinders the proliferation and development of malignant cells through its unique composition. This drug activity demonstrated its potential ability to inhibit breast, lung, prostate, and colon malignancies. | | Excitation / Emission Maximum | 655 nm/680 nm |
| | 4,4'''-bis[(2-butyloctyl)oxy]-1,1':4',1'':4'',1'''-quaterphenyl Preparation Products And Raw materials |
|